Pharmacist Prescribing Scope of Practice

• PSA is working with the state health department to have the PSA course recognised.

NSW Health recognises trained Queensland pharmacists who have completed the JCU and/or QUT training able to provide treatment to eligible people for certain additional conditions.

PSA is working with the state health department to have the PSA course recognised.

For more details visit, Expanded scope services – accessing care at your local pharmacy

PSA is working with the Territory Health Department to have the PSA course recognised.

From 1 July 2025, pharmacists that have completed additional training and meet the requirements set out in the Extended Practice Authority – Pharmacists are able to provide clinical advice and treatment (which may include prescribing medicines) for a range of acute common condition and health and wellbeing services.

These conditions and services include:

· Gastro-oesophageal reflux and gastro-oesophageal reflux disease

· Acute nausea and vomiting

· Allergic and nonallergic rhinitis

· Impetigo

· Hormonal contraception

· Herpes zoster (shingles)

· Mild to moderate atopic dermatitis

· Acute exacerbations of mild plaque psoriasis

· Mild to moderate acne

· Acute minor wound management

· Acute diffuse otitis externa

· Acute otitis media

· Acute mild musculoskeletal pain and inflammation

· Smoking cessation

· Oral health screening and fluoride application

· Travel health

· Management of overweight and obesity

In addition to these business-as-usual prescribing services, pharmacists with additional training can provide chronic conditions management services under the Queensland Community Pharmacy Chronic Conditions Management Pilot. This pilot will run until 30 June 2026.

Pharmacists who complete the PSA Prescribing training program (PTP) and Clinical practice training are eligible to deliver these expanded clinical services under the Extended Practice Authority – Pharmacists  and Extended Practice Authority – Pharmacists – Community pharmacy chronic conditions management pilot.

For more details, visit Community Pharmacy Prescribing in Queensland.

Community Pharmacy Expanded Scope of Practice Initiative

Under the new Community Pharmacy Expanded Scope of Practice Initiative (the Initiative), South Australians will be able to attend a local pharmacy to access additional high quality healthcare advice and services for a broader range of common health conditions from trained pharmacists.

Expanding the scope of practice of pharmacists will provide consumers with additional healthcare access and options, and support, reducing pressure on the health system including emergency departments and primary care.

PSA is working with the state health department to have the PSA course recognised.

For more details visit, Community Pharmacy Expanded Scope of Practice initiative | SA Health

Tasmanian pharmacists are required to undertake a Graduate Certificate level course, enrol now in PSA’s 11404NAT Graduate Certificate in Pharmacist Prescribing.

The Tasmanian Government has offered postgraduate scholarships that will subsidise full scope of practice training for pharmacists. These subsidies will directly reduce the cost of completing the required credentials.

Each successful applicant will receive up to $7,000 in support, with $3,500 available following enrolment and a further $3,500 on completion of the training. The first round of scholarship applications has closed – further rounds may follow depending on demand.

PSA’s 11404NAT Graduate Certificate in Pharmacist Prescribing meets the Tasmanian Government’s requirements – Enrol now!

The Victorian Government is expanding the role of community pharmacists under the Community Pharmacist Program.

Now known as the “Chemist Care Now” program, pharmacists who have completed a postgraduate Pharmacist Prescriber program accredited with the Australian Pharmacy Council are eligible to practice in the Victorian Community Pharmacy Program. This includes PSA’s Pharmacist Prescriber Training.

Pharmacists who complete PSA’s Pharmacist Prescriber Training are authorised to supply medicines without prescriptions under the program, when adhering to the Management Protocols published by the Department of Health – https://www.health.vic.gov.au/primary-care/community-pharmacist-program-resources-for-pharmacists. Pharmacists will self-declare the conditions/treatments they are trained in and able to provide, based on the clinical training they complete alongside the prescribing competence. PSA’s Clinical Practice Training Program covers current protocols and the expanded 22 conditions announced by the Victorian Premier in November 2024 that will be added to the Chemist Care Now Program in the future.

For more details about the Victorian specific program rules, visit Community Pharmacist Program | health.vic.gov.au

The Enhanced Access Community Pharmacy Pilot aims to provide Western Australians with additional access to treatment for a range of common health conditions.

Pharmacists who have completed an approved university graduate certificate course will be able to assess, manage, and treat a range of conditions in a community pharmacy setting and be able to prescribe certain Schedule 4 medications.

Service delivery is expected to commence by 2027, following the completion of pharmacist postgraduate training and finalisation of regulatory amendments. The pilot is anticipated to continue until 2028.

PSA is working with the state health department to have the PSA course recognised.

For more details visit, Enhanced Access Community Pharmacy Pilot.